Table 1 Comparison between diabetic and non-diabetic patients. General characteristics
From: Abnormalities in ambulatory blood pressure monitoring in hypertensive patients with diabetes
Variable | Patients with diabetes | Patients without diabetes | Significance a |
---|---|---|---|
Basic characteristics | |||
Number | 12 600 | 55 445 | |
Age (years) | 63.8±11.5 | 57.3±14.1 | <0.001 |
Male subjects (%) | 55.4 | 52.6 | <0.001 |
Duration of hypertension (years) | 7.20±8.01 | 5.57±6.84 | <0.001 |
BMI (kg m−2) | 30.1±4.92 | 28.6±4.52 | <0.001 |
Overweight, BMI 25 to <30 kg m−2 (%) | 40.6 | 46.2 | <0.001 |
Obesity, BMI ⩾30 kg m−2 (%) | 47.0 | 33.3 | <0.001 |
Fasting glucose (mg dl−1) | 142.4±43.2 | 97.2±14.2 | <0.001 |
Accompanying risk factors b | |||
Family with premature vascular disease (%) | 13.3 | 12.6 | 0.045 |
Smoking (%) | 14.2 | 17.3 | <0.001 |
Dyslipidaemia (%) | 59.3 | 33.2 | <0.001 |
Abdominal obesity (%) | 52.0 | 39.3 | <0.001 |
Target organ damage b | |||
Any manifestation of subclinical damage (%) | 25.0 | 10.9 | <0.001 |
Established vascular disease b | |||
Coronary heart disease (%) | 11.3 | 4.6 | <0.001 |
Cerebrovascular disease (%) | 6.5 | 3.4 | <0.001 |
Congestive heart failure | 3.3 | 1.5 | <0.001 |
Renal disease (%) | 3.8 | 1.3 | <0.001 |
Any cardiovascular disease | 21.6 | 9.9 | <0.001 |
Antihypertensive treatment | |||
Non-drug treatment (%) | 21.0 | 39.5 | <0.001 |
Monotherapy (%) | 20.0 | 23.4 | <0.001 |
Receiving a two-drug combination (%) | 25.1 | 20.2 | <0.001 |
Receiving a three-drug combination (%) | 20.2 | 11.4 | <0.001 |
Receiving four or more drugs (%) | 13.6 | 5.6 | <0.001 |
Mean number of antihypertensive drugs | 1.71±1.43 | 1.25±1.27 | <0.001 |
Type of drug | |||
ACE inhibitors (%) | 21.7 | 10.0 | <0.001 |
ARBs (%) | 28.8 | 16.1 | <0.001 |
Diuretics (%) | 40.0 | 26.5 | <0.001 |
Calcium antagonists (%) | 26.7 | 14.7 | <0.001 |
β-blockers (%) | 19.7 | 16.4 | <0.001 |
α-blockers (%) | 10.4 | 4.9 | <0.001 |
Other (%) | 1.0 | 0.5 | <0.001 |